Treatment response by IL28B genotype and KIR3DS1/Bw4.

Figshare2015-12-02 更新2026-04-29 收录

丙型肝炎治疗

病毒学预测

数据链接：

https://figshare.com/articles/dataset/_Treatment_response_by_IL28B_genotype_and_KIR3DS1_Bw4_/683495 数据链接链接失效反馈

官方服务：

资源简介：

Legend: interleukin 28B (IL28B), rapid virological response (RVR), sustained virological response (SVR).

创建时间：

2015-12-02

Treatment Effectiveness of Patients with Hepatitis C in the Prisons of Southern Taiwan: A Real-life Retrospective Analysis

丙型肝炎治疗

监狱医疗

Objective Hepatitis C is an important risk factor for cirrhosis and liver cancer in the Taiwanese population. Domestic prisons reported a higher rate of hepatitis C infection than the

DataCite Commons2023-04-21 更新80

Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro

药物代谢

丙型肝炎治疗

Paritaprevir (PTV) is a non-structural protein 3/4A protease inhibitor developed for the treatment of hepatitis C disease as a fixed dose combination of ombitasvir (OBV) and ritonavir (RTV) with or wi

DataCite Commons2020-08-28 更新40

Dataset from An Open-Label Study to Evaluate the Safety and Efficacy of the Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Chronic Hepatitis C Virus Genotype 4 Infection in Egypt

丙型肝炎治疗

药物临床试验

This study evaluates the efficacy and safety of ABT-450/r/ABT-267 with RBV in treatment-naive and treatment-experienced HCV GT4 subjects without or with compensated cirrhosis.

NIAID Data Ecosystem10

丙型肝炎治疗

直接抗病毒药物荟萃分析

This data archive contains the following 7 files relating to treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: - Supplementary figure 1: Thematic map

NIAID Data Ecosystem50

Characteristics of genotype 4 hepatitis C patients treated with simeprevir plus sofosbuvir with or without ribavirin.

丙型肝炎治疗

病毒药物疗效

Characteristics of genotype 4 hepatitis C patients treated with simeprevir plus sofosbuvir with or without ribavirin.

NIAID Data Ecosystem40